Patents for C12P 21 - Preparation of peptides or proteins (112,499)
03/2011
03/31/2011US20110077203 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
03/31/2011US20110077199 Growth hormone polypeptides and methods of making and using same
03/31/2011US20110077197 Novel insulin derivatives having an extremely delayed time-action profile
03/31/2011US20110076723 Antibody-peptide fused synergibody
03/31/2011US20110076722 Stable multivalent antibody
03/31/2011US20110076721 Efficient production of heterologous proteins using mannosyl transferase inhibitors
03/31/2011US20110076720 Nicking endonuclease methods and compositions
03/31/2011US20110076719 Substantially Animal Protein-Free Recombinant Furin and Methods for Producing the Same
03/31/2011US20110076718 In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
03/31/2011US20110076699 Hemolysin and its protein fragments in sero-detection of anaplasma phagocytophilum
03/31/2011US20110076275 Method of Modifying Isoelectric Point of Antibody Via Amino Acid Substitution in CDR
03/31/2011US20110076268 Antibodies against human respiratory syncytial virus (RSV) and methods of use
03/31/2011US20110076262 Humanized anti-fgf19 antagonists and methods using same
03/31/2011US20110076257 Modified Nucleotide Sequence Encoding Glucagon-Like Peptide-1 (GLP-1), Nucleic Acid Construct Comprising Same for Production of Glucagon-Like Peptide-1 (GLP-1), Human Cells Comprising Said Construct and Insulin-Producing Constructs, and Method of Use Thereof
03/31/2011CA2775465A1 High-yield antibiotics producing fungus strain, preparation method and use thereof
03/31/2011CA2774692A1 Bacterial strain for recombinant protein expression, having protease deficient degp retaining chaperone activity, and knocked out tsp and ptr genes
03/31/2011CA2773240A1 Process for producing molecules containing specialized glycan structures
03/31/2011CA2772230A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
03/30/2011EP2302068A1 Process for the preparation of recombinant polypeptides
03/30/2011EP2302059A1 Modifications of hiv Env, Gag, and Pol enhance immunogenicity for genetic immunization
03/30/2011EP2302058A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation
03/30/2011EP2302047A1 Protein glycosylation modification in Pichia pastoris
03/30/2011EP2301970A1 Human antibodies that bind human IL-12 and methods for producing
03/30/2011EP2301958A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
03/30/2011EP2301947A2 Secreted proteins and uses thereof
03/30/2011EP2301629A2 Anti-interferon-alpha antibodies
03/30/2011EP2301582A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
03/30/2011EP2301581A1 Production and use of novel peptide-based agents for use with B1-specific antibodies
03/30/2011EP2301580A1 Anti-VEGF antibodies
03/30/2011EP2301578A2 Methods for treating TWEAK-related conditions
03/30/2011EP2301577A2 Methods for treating TWEAK-related conditions
03/30/2011EP2300597A1 Modified pichia strain
03/30/2011EP2300446A1 Efficient production of heterologous proteins using mannosyl transferase inhibitors
03/30/2011EP1500698B1 Cell with depression or deletion of the activity of protein participating in gdp-fucose transport
03/30/2011EP1426764B1 Method of diagnosing or monitoring saccharometabolic error
03/30/2011EP1394261B1 Antigens for immunisation
03/30/2011CN101998965A Immunosuppressive polypeptides and nucleic acid
03/30/2011CN101993908A Method for treating eupolyphaga sinensis walker antioxidant peptide
03/30/2011CN101993907A Transgenic plants expressing CIVPS or intein modified proteins and related method
03/30/2011CN101993906A Transgenic plants expressing CIVPS or intein modified proteins and related method
03/30/2011CN101993888A Method for producing and recombining main allergic protein Hum j 3 of Humulus scandens by induced secretion expression
03/30/2011CN101993885A Novel high-efficiency recombinant plasmid vector and application thereof
03/30/2011CN101993851A New expression and preparation method of gene-recombinant Exendin-4
03/30/2011CN101993497A Human proliferation-inducing ligand blocking agent and preparation method and application thereof
03/30/2011CN101993496A Dual blood sugar and blood fat adjusting fusion protein and preparation method and application thereof
03/30/2011CN101993495A Protein mixture and preparation method thereof
03/30/2011CN101993493A Anti-tumor monoclonal antibody and preparation method and application thereof
03/30/2011CN101993491A Antibody combined with tubercle bacillus bacteriophage head protein as well as preparation method and application thereof
03/30/2011CN101993490A Antibody combined with tubercle bacillus bacteriophage tail protein as well as preparation method and application thereof
03/30/2011CN101993478A Multi-epitope recombinant protein of epstein-barr (EB) virus latent membrane protein 2 and application thereof
03/30/2011CN101993476A Casein active single peptide as well as preparation method and application thereof
03/30/2011CN101993281A Culture medium of ganoderma capense (Lloyd) Teng fungus for preparing Baozhi glycopeptide injection
03/30/2011CN101993161A Diosgenin industrial wastewater processing method and new process for co-producing GSH (glutathione) and SAM (methionine)
03/30/2011CN101991844A Edwardsiella tarda recombinant subunit vaccine and application thereof
03/30/2011CN101638681B Two aqueous phase extraction method for ocean pearl shell aminoglycoside
03/30/2011CN101240311B Method for producing soybean polypeptide albumen powder by biological fermentation
03/29/2011US7915396 Nucleic acid molecules encoding minimally immunogenic variants of SDR-grafted humanized antibody CC49
03/29/2011US7915395 Plasmid coding immunogenic fusion protein for use as drug delivery tool; antiproliferative agents; genetic vaccines
03/29/2011US7915390 Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases
03/29/2011US7915389 Anti-acharan sulfate antibody and its application
03/29/2011US7915388 Antigen binding domains; complementarity determining regions
03/29/2011US7915382 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith
03/29/2011US7915380 Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
03/29/2011US7915201 Ligational encoding of small molecules
03/29/2011US7915052 Immunoglobulin peptides against heated bovine blood
03/29/2011US7915041 Hybridoma capable of producing anti-dectin-1 monoclonal antibody
03/29/2011US7915025 In vivo incorporation of unnatural amino acids
03/29/2011US7915022 Carbonyl reductase, gene thereof and method of using the same
03/29/2011US7915011 Host cell modifications that improve peptide production and downstream processing
03/29/2011US7915010 DNA molecules encoding L-glutamate-gated chloride channels from Rhipicephalus sanguineus
03/29/2011US7915009 Modulating NF-kappa B by administering antigens or polynucleotide encoding antigens, antibody; treating cancer, tumor, Alzheimer's disease or a spongiform encephalopathy; DNA vaccine in kits
03/29/2011US7915008 Methods for isolation and analysis of sialylated and phosphorylated peptides
03/29/2011US7915004 Monoclonal antibodies, hybridomas, improved method for determining the protein PTX3 and kit for said determination
03/29/2011US7914795 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof
03/29/2011US7914792 Methods and compounds for raising antibodies and for screening antibody repertoires
03/29/2011US7914790 Human IgM antibody lysing activated lymphocytes under mediation by homologous complement
03/29/2011US7914784 Insulin-like growth factor I receptor (IGF-IR) specific monoclonal antibodies for diagnosis, prevention and treatment of cell proliferative disorders
03/29/2011CA2666053C Nucleic acids encoding recombinant protein a
03/29/2011CA2489475C A method for simultaneous production of multiple proteins; vectors and cells for use therein
03/29/2011CA2447040C Assays, methods and means
03/29/2011CA2436980C Amido ether substituted imidazoquinolines
03/29/2011CA2390652C Human circulating virus-inhibiting peptide (virip) and its use
03/29/2011CA2379571C Process for the production of a heterologous peptide by autoproteolytic cleavage in vitro
03/29/2011CA2344974C Chimaeric proteins between members of tgf-beta superfamily
03/29/2011CA2263798C G-coupled receptor showing selective affinity for atp
03/29/2011CA2256306C Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections
03/29/2011CA2252438C Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability
03/29/2011CA2207815C Modulators of the function of fas/apo1 receptors
03/29/2011CA2174354C Compositions of melanoma differentiation associated gene-7 (mda-7) in cancer diagnosis and treatment
03/29/2011CA2165573C Anti-.alpha.v-integrin monoclonal antibody
03/24/2011WO2011034969A1 Synergistic anti-cd47 therapy for hematologic cancers
03/24/2011WO2011034660A1 Class i anti-cea antibodies and uses thereof
03/24/2011WO2011034622A2 Inducible self-cleaving protease tag and method of purifying recombinant proteins using the same
03/24/2011WO2011034605A2 Coiled coil and/or tether containing protein complexes and uses thereof
03/24/2011WO2011034406A2 Rhodanobacter ginsenosidimutans kctc22231t-derived ginsenoside glycosidase, and use thereof
03/24/2011WO2011033961A1 Phospholipase a1, gene encoding phospholipase a1, expression vector, transformant, process for production of phospholipase a1
03/24/2011US20110072540 Polypeptides having beta-glucosidase activity and polynucleotides encoding same
03/24/2011US20110072526 Process for producing exogenous protein in the milk of transgenic mammals and a process for purifying proteins therefrom
03/24/2011US20110071278 Antibodies that recognize cutting edge within the tgf- beta activation controlling region
03/24/2011US20110071213 Card-domain containing polypeptides, encoding nucleic acids, and methods of use